Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
News|Slideshows|September 27, 2019
Aspirin: A Look Back at Its History
Author(s)Leo Robert
We take the long view on aspirin's history in this short slideshow. See how aspirin has shaped medicine from its discovery to the 18th century.
Advertisement
Recognition of the healing properties of aspirin can be traced to ancient Sumeria where the extract of willow leaves was first used to treat musculoskeletal pain, inflammation, and fever.In the slides below, we trace aspirin’s early history including geographic spread, expanding applications, and the increasing scientific rigor brought to evaluation of the drug’s properties and potential.
Advertisement
Related to this article
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears 15-Minute Blood Test to Help Distinguish Bacterial From Viral Infections
2
Evolocumab Tied to 20% Lower Risk of Myocardial Infarction vs Ezetimibe in Real-World Study
3
One Question PCPs Should Ask Every Patient with Atrial Fibrillation
4
Diagnosing Sleep Disturbances Beyond VMS in Menopause
5